“Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada” (2025) Canadian Allergy & Immunology Today, 5(s01), pp. 2–9. doi:10.58931/cait.2025.5s0176.